| Description | SARS-CoV-2 virus stock is produced by cell culture and formulated with purified, intact viral particles. The virus particles have been inactivated to render them non-infectious and refrigerator stable. The inactivation was verified in a standard microbiological growth protocol. SARS-CoV-2 stock can SARS-CoV-2 virus stock is produced by cell culture and formulated with purified, intact viral particles. The virus particles have been inactivated to render them non-infectious and refrigerator stable. The inactivation was verified in a standard microbiological growth protocol. SARS-CoV-2 stock can be used in the development of SARS-CoV-2 diagnostics and in vaccine development and R&D.... Read More | Blautia is a genus of anaerobic bacteria with probiotic characteristics that occur widely in the feces and intestines of mammals. | Cynomolgus monkey is widely used in medical experiments, especially those associated with neuroscience and disease. This product is isolated from normal Cynomolgus monkey prostate tissue. Cells are negative for bacteria, yeast, fungi, mycoplasma, and can be used for a variety of tests and assays Cynomolgus monkey is widely used in medical experiments, especially those associated with neuroscience and disease. This product is isolated from normal Cynomolgus monkey prostate tissue. Cells are negative for bacteria, yeast, fungi, mycoplasma, and can be used for a variety of tests and assays such as cell-cell interaction, adhesion, migration, PCR, Western blot, immunoprecipitation, immunofluorescent staining, immunofluorescent flow cytometry, or generating cell derivatives for desired research applications.... Read More | Recombinant Norovirus GI.1 Virus-like Particles (NoV GI.1 VLPs) are produced in Baculovirus/Insect cell expression system, assembled with VP1 structure protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material Recombinant Norovirus GI.1 Virus-like Particles (NoV GI.1 VLPs) are produced in Baculovirus/Insect cell expression system, assembled with VP1 structure protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. NoV GI.1 VLPs can be used in the development of NoV GI.1 diagnostics and in vaccine development and R&D (including use as an immunogen).... Read More | SARS-CoV-2 Inactivated Virus Particles is chemically modifie to be non-infectious intact viral particles. The inactivation was verified in a standard microbiological growth protocol. Based on our in-house RT-PCR assay to detect the N proteins, it indicates that our product includes 1,000,000 copies SARS-CoV-2 Inactivated Virus Particles is chemically modifie to be non-infectious intact viral particles. The inactivation was verified in a standard microbiological growth protocol. Based on our in-house RT-PCR assay to detect the N proteins, it indicates that our product includes 1,000,000 copies per mL.... Read More |